These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25527568)

  • 1. Cytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia.
    Medeiros BC; Othus M; Fang M; Appelbaum FR; Erba HP
    Haematologica; 2015 Mar; 100(3):331-5. PubMed ID: 25527568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials.
    Baron F; Stevens-Kroef M; Kicinski M; Meloni G; Muus P; Marie JP; Halkes CJM; Thomas X; Vrhovac R; Specchia G; Lefrere F; Sica S; Mancini M; Venditti A; Hagemeijer A; Becker H; Jansen JH; Amadori S; de Witte T; Willemze R; Suciu S
    Ann Hematol; 2018 Oct; 97(10):1785-1795. PubMed ID: 29926156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance).
    Niederwieser C; Nicolet D; Carroll AJ; Kolitz JE; Powell BL; Kohlschmidt J; Stone RM; Byrd JC; Mrózek K; Bloomfield CD
    Haematologica; 2016 Dec; 101(12):1516-1523. PubMed ID: 27470602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemia.
    Bochtler T; Stölzel F; Heilig CE; Kunz C; Mohr B; Jauch A; Janssen JW; Kramer M; Benner A; Bornhäuser M; Ho AD; Ehninger G; Schaich M; Krämer A
    J Clin Oncol; 2013 Nov; 31(31):3898-905. PubMed ID: 24062393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT.
    Brands-Nijenhuis AV; Labopin M; Schouten HC; Volin L; Socié G; Cornelissen JJ; Huynh A; Ljungman P; Malard F; Esteve J; Nagler A; Mohty M
    Haematologica; 2016 Feb; 101(2):248-55. PubMed ID: 26589909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapse and cytogenetic evolution in myeloid neoplasms.
    Ertz-Archambault N; Kelemen K
    Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype.
    Breems DA; Van Putten WL; De Greef GE; Van Zelderen-Bhola SL; Gerssen-Schoorl KB; Mellink CH; Nieuwint A; Jotterand M; Hagemeijer A; Beverloo HB; Löwenberg B
    J Clin Oncol; 2008 Oct; 26(29):4791-7. PubMed ID: 18695255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.
    Damiani D; Tiribelli M; Franzoni A; Michelutti A; Fabbro D; Cavallin M; Toffoletti E; Simeone E; Fanin R; Damante G
    Am J Hematol; 2013 Oct; 88(10):848-52. PubMed ID: 23760853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of immunophenotyping and gene mutations in elderly patients with acute myeloid leukemia with normal karyotype.
    Dang H; Jiang A; Kamel-Reid S; Brandwein J; Chang H
    Hum Pathol; 2013 Jan; 44(1):55-61. PubMed ID: 22939316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD11b expression correlates with monosomal karyotype and predicts an extremely poor prognosis in cytogenetically unfavorable acute myeloid leukemia.
    Chen MH; Atenafu E; Craddock KJ; Brandwein J; Chang H
    Leuk Res; 2013 Feb; 37(2):122-8. PubMed ID: 23092917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
    El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
    Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemia.
    Nahajevszky S; Andrikovics H; Batai A; Adam E; Bors A; Csomor J; Gopcsa L; Koszarska M; Kozma A; Lovas N; Lueff S; Matrai Z; Meggyesi N; Sinko J; Sipos A; Varkonyi A; Fekete S; Tordai A; Masszi T
    Haematologica; 2011 Nov; 96(11):1613-8. PubMed ID: 21791467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and biological prognostic factors in relapsed acute myeloid leukemia patients].
    Yébenes-Ramírez M; Serrano J; Martínez-Losada C; Sánchez-García J
    Med Clin (Barc); 2016 Sep; 147(5):185-191. PubMed ID: 27374030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal evolution detected with conventional cytogenetic analysis is a potent prognostic factor in adult patients with relapsed AML.
    Shimizu H; Yokohama A; Ishizaki T; Hatsumi N; Takada S; Saitoh T; Sakura T; Nojima Y; Handa H
    Hematol Oncol; 2018 Feb; 36(1):252-257. PubMed ID: 28378367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia.
    Lo-Coco F; Cuneo A; Pane F; Cilloni D; Diverio D; Mancini M; Testoni N; Bardi A; Izzo B; Bolli N; La Starza R; Fazi P; Iacobelli S; Piciocchi A; Vignetti M; Amadori S; Mandelli F; Pelicci PG; Mecucci C; Falini B; Saglio G;
    Haematologica; 2008 Jul; 93(7):1017-24. PubMed ID: 18508799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interest of cytogenetic and FISH evaluation for prognosis evaluation in 198 patients with acute myeloid leukemia in first complete remission in a single institution.
    Hirsch P; Labopin M; Viguié F; Perot C; Isnard F; Mamez AC; Bilhou-Nabera C; Marzac C; Delhommeau F; Lapusan S; Marie JP; Mohty M; Legrand O
    Leuk Res; 2014 Aug; 38(8):907-12. PubMed ID: 24957411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemia-associated aberrant immunophenotype in patients with acute myeloid leukemia: changes at refractory disease or first relapse and clinicopathological findings.
    Cui W; Zhang D; Cunningham MT; Tilzer L
    Int J Lab Hematol; 2014 Dec; 36(6):636-49. PubMed ID: 24602197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of Wilms tumor gene mutations in Egyptian patients with acute myeloid leukemia with normal karyotype.
    Zidan MA; Kamal Shaaban HM; Elghannam DM
    Hematology; 2014 Jul; 19(5):267-74. PubMed ID: 24074521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
    Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of monosomal karyotype in comparison to complex aberrant karyotype in acute myeloid leukemia: a study on 824 cases with aberrant karyotype.
    Haferlach C; Alpermann T; Schnittger S; Kern W; Chromik J; Schmid C; Pielken HJ; Kreuzer KA; Höffkes HG; Haferlach T
    Blood; 2012 Mar; 119(9):2122-5. PubMed ID: 22207733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.